Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Forums: Virtual Conferences
9th International Conference on Alzheimer's Disease and Related Disorders

Posted 21 May 2005

Return to 9th International Conference Index

Epidemiology of Alzheimer's Disease: Lessons from Cardiovascular Studies

By Leonore J. Launer, National Institute on Aging, Bethesda, MD, USA.

View Lenore Launer's presentation.

Dementia is the most common form of neurologic disease in the elderly; Alzheimer's disease (AD) comprises approximately 65% of cases. Epidemiologic studies are designed to measure rates of, etiologic factors for, and progression of dementia. Information from epidemiologic studies provides a means to validate etiologic factors investigated in laboratory research, and can also generate hypotheses to be tested under more controlled conditions. Epidemiologic studies over the past 10 years have given us new insights into the characteristics and progression of AD in community dwelling individuals. There is now sufficient data to suggest that AD may start many years before the subject meets clinical criteria for AD. The nature of this long progression, the degree to which endogenous and exogenous factors change with disease progression, and advances in technology will play a role in designing new epidemiologic studies. Objective: Provide specific examples illustrating the lessons we have learned about AD through epidemiologic studies. Discuss how we can apply these lessons to new studies. Results: The characteristics of community dwelling AD cases will be reviewed in the context of identifying phenotypes for future studies. The lessons about reverse causality, selective survival, changing environment, and individual variability will be discussed. Conclusions: Future epidemiologic studies will have to address the issues about AD that we have learned in the past decade.

Citation: NeuroBiology of Aging, Volume 25, Number S2, July 2004, Page 1

View Lenore Launer's presentation.
To hear the associated audio, click on the "Play Audio" button on each slide.


Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

Alzheimer's Association


The web presentations from the 9th International Conference on Alzheimer Disease and Related Disorders represent the collaborative efforts of the Alzheimer's Association and the Alzheimer Research Forum.

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad